MetaADEDB 2.0 @ LMMD
Hydralazine
(ZUXNZUWOTSUBMN-UHFFFAOYSA-N)
Structure
SMILES
NNc1nncc2c1cccc2.Cl
Molecular Formula:
C8H9ClN4
Molecular Weight:
196.637
Log P:
2.4907
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
3
TPSA:
63.83
CAS Number(s):
304-20-1; 81411-23-6; 1044569-46-1
Synonym(s)
1.
Hydralazine
2.
Hydrallazin
3.
Apresoline
4.
Apressin
5.
Apressoline
6.
Hydralazine Hydrochloride
7.
Hydralazine mono-Hydrochloride
8.
Hydrazinophthalazine
9.
Nepresol
10.
Hydralazine mono Hydrochloride
11.
Hydrochloride, Hydralazine
12.
mono-Hydrochloride, Hydralazine
External Link(s)
MeSHD006830
PubChem Compound135939247
9351
57516019
ChEBI31672
CHEMBLCHEMBL542541
KEGGdr:D01302
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Anti-neutrophil cytoplasmic antibody positive vasculitisFAERS: 80US FAERS
2VasculitisFAERS: 30US FAERS
3Lupus-like syndromeFAERS: 27US FAERS
4GlomerulonephritisFAERS: 26US FAERS
5HypotensionFAERS: 19US FAERS
6Acute kidney injuryFAERS: 15US FAERS
7Drug ineffectiveFAERS: 15US FAERS
8DizzinessFAERS: 14US FAERS
9NauseaFAERS: 14US FAERS
10HeadacheFAERS: 12US FAERS
11Maternal exposure during pregnancyFAERS: 12US FAERS
12ProteinuriaFAERS: 12US FAERS
13Chest PainFAERS: 11US FAERS
14ArthralgiaFAERS: 9US FAERS
15Low birth weight babyFAERS: 9US FAERS
16Lupus NephritisFAERS: 9US FAERS
17Toxicity to various agentsFAERS: 9US FAERS
18FlushingFAERS: 8US FAERS
19AstheniaFAERS: 7US FAERS
20Blood pressure inadequately controlledFAERS: 7US FAERS
21FatigueFAERS: 7US FAERS
22PalpitationsFAERS: 7US FAERS
23Pulmonary renal syndromeFAERS: 7US FAERS
24Renal vasculitisFAERS: 7US FAERS
25VomitingFAERS: 7US FAERS
26AnxietyFAERS: 6US FAERS
27Autoimmune hepatitisFAERS: 6US FAERS
28Drug dispensing errorFAERS: 6US FAERS
29Drug exposure during pregnancyFAERS: 6US FAERS
30Medication ErrorFAERS: 6US FAERS
31MyalgiaFAERS: 6US FAERS
32NephritisFAERS: 6US FAERS
33AngioedemaFAERS: 5US FAERS
34Cardiac ArrestFAERS: 5US FAERS
35Hepatic necrosisFAERS: 5US FAERS
36HypersensitivityFAERS: 5US FAERS
37MalaiseFAERS: 5US FAERS
38Respiratory distressFAERS: 5US FAERS
39TremorFAERS: 5US FAERS
40Blood creatinine increasedFAERS: 4US FAERS
41ChillsFAERS: 4US FAERS
42Epiglottis ulcerFAERS: 4US FAERS
43GangreneFAERS: 4US FAERS
44Pericardial effusionFAERS: 4US FAERS
45Product quality issueFAERS: 4US FAERS
46Supraventricular tachycardiaFAERS: 4US FAERS
47Angina PectorisFAERS: 3US FAERS
48ArthritisFAERS: 3US FAERS
49Chest discomfortFAERS: 3US FAERS
50ErythemaFAERS: 3US FAERS
51Histone antibody positiveFAERS: 3US FAERS
52HypocomplementaemiaFAERS: 3US FAERS
53Live BirthFAERS: 3US FAERS
54PericarditisFAERS: 3US FAERS
55Product label issueFAERS: 3US FAERS
56Respiratory FailureFAERS: 3US FAERS
57TachycardiaFAERS: 3US FAERS
58Antiphospholipid antibodies positiveFAERS: 2US FAERS
59Atrial FibrillationFAERS: 2US FAERS
60C3 glomerulopathyFAERS: 2US FAERS
61Cardiac TamponadeFAERS: 2US FAERS
62CheilitisFAERS: 2US FAERS
63Circumstance or information capable of leading to medication errorFAERS: 2US FAERS
64DehydrationFAERS: 2US FAERS
65DysphoniaFAERS: 2US FAERS
66EclampsiaFAERS: 2US FAERS
67Eyelid rashFAERS: 2US FAERS
68Feeling ColdFAERS: 2US FAERS
69Feeling abnormalFAERS: 2US FAERS
70Hypertensive emergencyFAERS: 2US FAERS
71HypoxiaFAERS: 2US FAERS
72Incorrect dose administeredFAERS: 2US FAERS
73Joint swellingFAERS: 2US FAERS
74Leukocytoclastic vasculitisFAERS: 2US FAERS
75Lupus pneumonitisFAERS: 2US FAERS
76Mucocutaneous rashFAERS: 2US FAERS
77PainFAERS: 2US FAERS
78PancytopeniaFAERS: 2US FAERS
79Physical product label issueFAERS: 2US FAERS
80Pleuritic painFAERS: 2US FAERS
81PneumoniaFAERS: 2US FAERS
82Product dispensing errorFAERS: 2US FAERS
83PurpuraFAERS: 2US FAERS
84Retinal VasculitisFAERS: 2US FAERS
85Septic ShockFAERS: 2US FAERS
86SwellingFAERS: 2US FAERS
87TinnitusFAERS: 2US FAERS
88Tongue eruptionFAERS: 2US FAERS
89UrticariaFAERS: 2US FAERS
90Wrong drug administeredFAERS: 2US FAERS
91jaundiceFAERS: 2US FAERS
92Abdominal PainFAERS: 1US FAERS
93Abdominal discomfortFAERS: 1US FAERS
94Accidental overdoseFAERS: 1US FAERS
95Acquired porphyriaFAERS: 1US FAERS
96Activities of daily living impairedFAERS: 1US FAERS
97AgitationFAERS: 1US FAERS
98AgranulocytosisFAERS: 1US FAERS
99Alanine Aminotransferase IncreasedFAERS: 1US FAERS
100AlopeciaFAERS: 1US FAERS
101Anaphylactoid syndrome of pregnancyFAERS: 1US FAERS
102AngerFAERS: 1US FAERS
103Antinuclear antibody increasedFAERS: 1US FAERS
104AphasiaFAERS: 1US FAERS
105Arterial thrombosisFAERS: 1US FAERS
106AscitesFAERS: 1US FAERS
107Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
108Atrial FlutterFAERS: 1US FAERS
109Autoimmune nephritisFAERS: 1US FAERS
110Back PainFAERS: 1US FAERS
111Bicuspid aortic valveFAERS: 1US FAERS
112Blood sodium decreasedFAERS: 1US FAERS
113Blood urea increasedFAERS: 1US FAERS
114Blood urine presentFAERS: 1US FAERS
115Cardiac enzymes increasedFAERS: 1US FAERS
116Cardiac infectionFAERS: 1US FAERS
117Carotid artery occlusionFAERS: 1US FAERS
118Cerebrovascular accidentFAERS: 1US FAERS
119CholecystitisFAERS: 1US FAERS
120CholelithiasisFAERS: 1US FAERS
121CholestasisFAERS: 1US FAERS
122ChromaturiaFAERS: 1US FAERS
123Complement factor C3 decreasedFAERS: 1US FAERS
124Complement factor C4 decreasedFAERS: 1US FAERS
125Congenital anomaly in offspringFAERS: 1US FAERS
126ConstipationFAERS: 1US FAERS
127Contraindicated drug administeredFAERS: 1US FAERS
128CyanosisFAERS: 1US FAERS
129Depressed Level of ConsciousnessFAERS: 1US FAERS
130Diffuse alveolar damageFAERS: 1US FAERS
131Disseminated Intravascular CoagulationFAERS: 1US FAERS
132Diverticular perforationFAERS: 1US FAERS
133Double stranded DNA antibody positiveFAERS: 1US FAERS
134Drug effect incompleteFAERS: 1US FAERS
135Drug prescribing errorFAERS: 1US FAERS
136Dry gangreneFAERS: 1US FAERS
137Electrocardiogram U-wave abnormalityFAERS: 1US FAERS
138Emotional disorderFAERS: 1US FAERS
139EpistaxisFAERS: 1US FAERS
140Gastrointestinal melanosisFAERS: 1US FAERS
141GoutFAERS: 1US FAERS
142Granulomatosis with polyangiitisFAERS: 1US FAERS
143HELLP SyndromeFAERS: 1US FAERS
144Hepatic infection bacterialFAERS: 1US FAERS
145HepatitisFAERS: 1US FAERS
146HypophagiaFAERS: 1US FAERS
147IgM nephropathyFAERS: 1US FAERS
148Impaired driving abilityFAERS: 1US FAERS
149Impaired work abilityFAERS: 1US FAERS
150InfectionFAERS: 1US FAERS
151InflammationFAERS: 1US FAERS
152LeukopeniaFAERS: 1US FAERS
153Livedo ReticularisFAERS: 1US FAERS
154Mental status changesFAERS: 1US FAERS
155Mesangioproliferative glomerulonephritisFAERS: 1US FAERS
156Mood swingsFAERS: 1US FAERS
157Multiple MyelomaFAERS: 1US FAERS
158MyocarditisFAERS: 1US FAERS
159NephrosclerosisFAERS: 1US FAERS
160Nephrotic SyndromeFAERS: 1US FAERS
161Night sweatsFAERS: 1US FAERS
162Oropharyngeal painFAERS: 1US FAERS
163PallorFAERS: 1US FAERS
164ParanoiaFAERS: 1US FAERS
165Peripartum cardiomyopathyFAERS: 1US FAERS
166PetechiaeFAERS: 1US FAERS
167Product use in unapproved indicationFAERS: 1US FAERS
168Productive CoughFAERS: 1US FAERS
169PruritusFAERS: 1US FAERS
170Quality of life decreasedFAERS: 1US FAERS
171RalesFAERS: 1US FAERS
172Rash erythematousFAERS: 1US FAERS
173Rheumatoid ArthritisFAERS: 1US FAERS
174SepsisFAERS: 1US FAERS
175SerositisFAERS: 1US FAERS
176Skin UlcerFAERS: 1US FAERS
177Skin lesionFAERS: 1US FAERS
178SyncopeFAERS: 1US FAERS
179Tension HeadacheFAERS: 1US FAERS
180TensionFAERS: 1US FAERS
181ThrombocytopeniaFAERS: 1US FAERS
182Transaminases increasedFAERS: 1US FAERS
183Troponin increasedFAERS: 1US FAERS
184Vanishing bile duct syndromeFAERS: 1US FAERS
185Venous ThrombosisFAERS: 1US FAERS
186VertigoFAERS: 1US FAERS
187Weight decreasedFAERS: 1US FAERS
188WheezingFAERS: 1US FAERS
189nervous system disorderFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.